{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:08:23Z","timestamp":1740143303661,"version":"3.37.3"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,2,27]],"date-time":"2018-02-27T00:00:00Z","timestamp":1519689600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100002665","name":"Research Committee, Aristotle University of Thessaloniki","doi-asserted-by":"publisher","award":["88228"],"award-info":[{"award-number":["88228"]}],"id":[{"id":"10.13039\/501100002665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Forensic Sci Med Pathol"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s12024-018-9960-3","type":"journal-article","created":{"date-parts":[[2018,2,27]],"date-time":"2018-02-27T03:19:58Z","timestamp":1519701598000},"page":"225-228","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Fatal intoxication with antidepressants: a case with many culprits"],"prefix":"10.1007","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6189-594X","authenticated-orcid":false,"given":"Antonis","family":"Goulas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaos","family":"Raikos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diamantis","family":"Krokos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orthodoxia","family":"Mastrogianni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amvrosios","family":"Orphanidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Zisopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Androniki","family":"Tsepa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,2,27]]},"reference":[{"key":"9960_CR1","first-page":"241","volume":"25","author":"K Bezchlibnyk-Butler","year":"2000","unstructured":"Bezchlibnyk-Butler K, Aleksic I, Kennedy SH. Citalopram--a review of pharmacological and clinical effects. J Psychiatry Neurosci. 2000;25:241\u201354.","journal-title":"J Psychiatry Neurosci"},{"key":"9960_CR2","unstructured":"http:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm297391.htm . Accessed 5 Jan 2018."},{"key":"9960_CR3","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s10928-005-0022-6","volume":"32","author":"LE Friberg","year":"2005","unstructured":"Friberg LE, Isbister GK, Hackett LP, Duffull SB. The population pharmacokinetics of citalopram after deliberate self-poisoning: a Bayesian approach. J Pharmacokinet Pharmacodyn. 2005;32:571\u2013605.","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"9960_CR4","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00414-010-0536-3","volume":"125","author":"JL Pilgrim","year":"2011","unstructured":"Pilgrim JL, Gerostamoulos D, Drummer OH. Deaths involving contraindicated and inappropriate combinations of serotonergic drugs. Int J Legal Med. 2011;125:803\u201315.","journal-title":"Int J Legal Med"},{"key":"9960_CR5","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1007\/s12024-010-9188-3","volume":"7","author":"JL Pilgrim","year":"2011","unstructured":"Pilgrim JL, Gerostamoulos D, Drummer OH. Review: pharmacogenetic aspects of the effect of cytochrome P450 polymorphisms on serotonergic drug metabolism, response, interactions, and adverse effects. Forensic Sci Med Pathol. 2011;7:162\u201384.","journal-title":"Forensic Sci Med Pathol"},{"key":"9960_CR6","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1056\/NEJMra041867","volume":"352","author":"EW Boyer","year":"2005","unstructured":"Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352:1112\u201320.","journal-title":"N Engl J Med"},{"key":"9960_CR7","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.euroneuro.2016.02.001","volume":"26","author":"CJ Bachmann","year":"2016","unstructured":"Bachmann CJ, Aagaard L, Burcu M, Glaeske G, Kalverdijk LJ, Petersen I, et al. Trends and patterns of antidepressant use in children and adolescents from five western countries, 2005-2012. Eur Neuropsychopharmacol. 2016;26:411\u20139.","journal-title":"Eur Neuropsychopharmacol"},{"key":"9960_CR8","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/j.1527-3458.2004.tb00005.x","volume":"10","author":"K Gillman","year":"2004","unstructured":"Gillman K. Moclobemide and the risk of serotonin toxicity (or serotonin syndrome). CNS Drug Rev. 2004;10:83\u20135.","journal-title":"CNS Drug Rev."},{"key":"9960_CR9","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1093\/jat\/25.2.147","volume":"25","author":"R Dams","year":"2001","unstructured":"Dams R, Benijts TH, Lambert WE, Van Bocxlaer JF, Van Varenbergh D, Van Peteghem C, et al. A fatal case of serotonin syndrome after combined moclobemide-citalopram intoxication. J Anal Toxicol. 2001;25:147\u201351.","journal-title":"J Anal Toxicol"},{"key":"9960_CR10","first-page":"644","volume":"34","author":"ML Wu","year":"2011","unstructured":"Wu ML, Deng JF. Fatal serotonin toxicity caused by moclobemide and fluoxetine overdose. Chang Gung Med J. 2011;34:644\u20139.","journal-title":"Chang Gung Med J"},{"key":"9960_CR11","doi-asserted-by":"publisher","first-page":"215","DOI":"10.2133\/dmpk.DMPK-13-NT-092","volume":"29","author":"O Mastrogianni","year":"2014","unstructured":"Mastrogianni O, Gbandi E, Orphanidis A, Raikos N, Goutziomitrou E, Kolibianakis EM, et al. Association of the CYP2B6 c.516G>T polymorphism with high blood propofol concentrations in women from northern Greece. Drug Metab Pharmacokinet. 2014;29:215\u20138.","journal-title":"Drug Metab Pharmacokinet"},{"key":"9960_CR12","doi-asserted-by":"publisher","unstructured":"Papazisis G, Goulas A, Sarrigiannidis A, Bargiota S, Antoniadis D, Raikos N, et al. ABCB1 and CYP2D6 polymorphisms and treatment response of psychotic patients in a naturalistic setting. Hum Psychopharmacol. 2018; https:\/\/doi.org\/10.1002\/hup.2644 .","DOI":"10.1002\/hup.2644"},{"key":"9960_CR13","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1002\/dta.1507","volume":"6","author":"T Launiainen","year":"2014","unstructured":"Launiainen T, Ojanper\u00e4 I. Drug concentrations in post-mortem femoral blood compared with therapeutic concentrations in plasma. Drug Test Anal. 2014;6:308\u201316.","journal-title":"Drug Test Anal"},{"key":"9960_CR14","doi-asserted-by":"crossref","unstructured":"Winek CL, Wahba WW, Winek CL Jr, Balzer TW. Drug and chemical blood-level data 2001. Forensic Sci Int 2001;122:107\u2013123.","DOI":"10.1016\/S0379-0738(01)00483-2"},{"key":"9960_CR15","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.forsciint.2004.02.017","volume":"142","author":"F Musshoff","year":"2004","unstructured":"Musshoff F, Padosch S, Steinborn S, Madea B. Fatal blood and tissue concentrations of more than 200 drugs. Forensic Sci Int. 2004;142:161\u2013210.","journal-title":"Forensic Sci Int"},{"key":"9960_CR16","doi-asserted-by":"publisher","first-page":"R136","DOI":"10.1186\/cc11441","volume":"16","author":"M Schulz","year":"2012","unstructured":"Schulz M, Iwersen-Bergmann S, Andresen H, Schmoldt A. Therapeutic and toxic blood concentrations of nearly 1,000 drugs and other xenobiotics. Crit Care. 2012;16:R136.","journal-title":"Crit Care"},{"key":"9960_CR17","doi-asserted-by":"crossref","unstructured":"Hooten WM, Hartman WR, Black JL 3rd, Laures HJ, Walker DL. Associations between serotonin transporter gene polymorphisms and heat pain perception in adults with chronic pain. BMC Med Genet 2013;14:78.","DOI":"10.1186\/1471-2350-14-78"},{"key":"9960_CR18","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1007\/s00414-016-1358-8","volume":"130","author":"I Ojanper\u00e4","year":"2016","unstructured":"Ojanper\u00e4 I, Kriikku P, Vuori E. Fatal toxicity index of medicinal drugs based on a comprehensive toxicology database. Int J Legal Med. 2016;130:1209\u201316.","journal-title":"Int J Legal Med"},{"key":"9960_CR19","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1093\/jat\/24.7.648","volume":"24","author":"K Fu","year":"2000","unstructured":"Fu K, Konrad RJ, Hardy RW, Brissie RM, Robinson CA. An unusual multiple drug intoxication case involving citalopram. J Anal Toxicol. 2000;24:648\u201350.","journal-title":"J Anal Toxicol"},{"key":"9960_CR20","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1093\/jat\/13.5.305","volume":"13","author":"TP Rohrig","year":"1989","unstructured":"Rohrig TP, Prouty RW. Fluoxetine overdose: a case report. J Anal Toxicol. 1989;13:305\u20137.","journal-title":"J Anal Toxicol"},{"key":"9960_CR21","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1191\/0960327103ht324oa","volume":"22","author":"A Koski","year":"2003","unstructured":"Koski A, Ojanper\u00e4 I, Vuori E. Interaction of alcohol and drugs in fatal poisonings. Hum Exp Toxicol. 2003;22:281\u20137.","journal-title":"Hum Exp Toxicol"},{"key":"9960_CR22","first-page":"453","volume":"1","author":"DA Collier","year":"1996","unstructured":"Collier DA, St\u00f6ber G, Li T, Heils A, Catalano M, Di Bella D, et al. A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders. Mol Psychiatry. 1996;1:453\u201360.","journal-title":"Mol Psychiatry"},{"key":"9960_CR23","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1002\/phar.1978","volume":"37","author":"J Zhu","year":"2017","unstructured":"Zhu J, Klein-Fedyshin M, Stevenson JM. Serotonin transporter gene polymorphisms and selective serotonin reuptake inhibitor tolerability: review of pharmacogenetic evidence. Pharmacotherapy. 2017;37:1089\u2013104.","journal-title":"Pharmacotherapy"},{"key":"9960_CR24","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s10072-011-0546-z","volume":"32","author":"G Talarico","year":"2011","unstructured":"Talarico G, Tosto G, Pietracupa S, Piacentini E, Canevelli M, Lenzi GL, et al. Serotonin toxicity: a short review of the literature and two case reports involving citalopram. Neurol Sci. 2011;32:507\u20139.","journal-title":"Neurol Sci"},{"key":"9960_CR25","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1055\/s-0032-1326769","volume":"45","author":"S Unterecker","year":"2012","unstructured":"Unterecker S, Warrings B, Deckert J, Pfuhlmann B. Correlation of QTc interval prolongation and serum level of citalopram after intoxication--a case report. Pharmacopsychiatry. 2012;45:30\u20134.","journal-title":"Pharmacopsychiatry"},{"key":"9960_CR26","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1089\/cap.2006.0144","volume":"17","author":"S Kronenberg","year":"2007","unstructured":"Kronenberg S, Apter A, Brent D, Schirman S, Melhem N, Pick N, et al. Serotonin transporter polymorphism (5-HTTLPR) and citalopram effectiveness and side effects in children with depression and\/or anxiety disorders. J Child Adolesc Psychopharmacol. 2007;17:741\u201350.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"9960_CR27","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1126\/science.1083968","volume":"301","author":"A Caspi","year":"2003","unstructured":"Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science. 2003;301:386\u20139.","journal-title":"Science"},{"key":"9960_CR28","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1038\/npp.2013.73","volume":"38","author":"J Cao","year":"2013","unstructured":"Cao J, Hudziak JJ, Li D. Multi-cultural association of the serotonin transporter gene (SLC6A4) with substance use disorder. Neuropsychopharmacology. 2013;38:1737\u201347.","journal-title":"Neuropsychopharmacology"},{"key":"9960_CR29","doi-asserted-by":"publisher","first-page":"531","DOI":"10.3109\/08039488.2015.1012554","volume":"69","author":"K Andre","year":"2015","unstructured":"Andre K, Kampman O, Illi A, Viikki M, Set\u00e4l\u00e4-Soikkeli E, Mononen N, et al. SERT and NET polymorphisms, temperament and antidepressant response. Nord J Psychiatry. 2015;69:531\u20138.","journal-title":"Nord J Psychiatry"},{"key":"9960_CR30","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/sjop.12124","volume":"55","author":"NI Landr\u00f8","year":"2014","unstructured":"Landr\u00f8 NI. Towards personalized treatment of depression: a candidate gene approach. Scand J Psychol. 2014;55:219\u201324.","journal-title":"Scand J Psychol"}],"container-title":["Forensic Science, Medicine and Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12024-018-9960-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12024-018-9960-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12024-018-9960-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T18:42:03Z","timestamp":1570819323000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12024-018-9960-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,27]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["9960"],"URL":"https:\/\/doi.org\/10.1007\/s12024-018-9960-3","relation":{},"ISSN":["1547-769X","1556-2891"],"issn-type":[{"type":"print","value":"1547-769X"},{"type":"electronic","value":"1556-2891"}],"subject":[],"published":{"date-parts":[[2018,2,27]]},"assertion":[{"value":"25 January 2018","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2018","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable; only data collected in the process of a routine medico-legal investigation ordered by the legal authorities are presented in this case report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"As above.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}